These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 25727856)

  • 1. Natural history of idiopathic pulmonary fibrosis.
    Kim HJ; Perlman D; Tomic R
    Respir Med; 2015 Jun; 109(6):661-70. PubMed ID: 25727856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting prognosis in idiopathic pulmonary fibrosis.
    Barlo NP; van Moorsel CH; van den Bosch JM; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(2):85-95. PubMed ID: 21319590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
    Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
    BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does comorbidity influence survival in idiopathic pulmonary fibrosis?
    Hyldgaard C; Hilberg O; Bendstrup E
    Respir Med; 2014 Apr; 108(4):647-53. PubMed ID: 24529739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience.
    Bennett D; Fossi A; Bargagli E; Refini RM; Pieroni M; Luzzi L; Ghiribelli C; Paladini P; Voltolini L; Rottoli P
    Lung; 2015 Oct; 193(5):677-81. PubMed ID: 26216722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic pulmonary fibrosis: evolving concepts.
    Ryu JH; Moua T; Daniels CE; Hartman TE; Yi ES; Utz JP; Limper AH
    Mayo Clin Proc; 2014 Aug; 89(8):1130-42. PubMed ID: 24867394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitions of disease: should possible and probable idiopathic pulmonary fibrosis be enrolled in treatment trials?
    Huie TJ; Brown KK
    Respir Investig; 2015 May; 53(3):88-92. PubMed ID: 25951093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of the prognosis of idiopathic pulmonary fibrosis.
    Novelli F; Tavanti L; Cini S; Aquilini F; Melosini L; Romei C; Sbragia P; Falaschi F; Celi A; Paggiaro P
    Eur Rev Med Pharmacol Sci; 2014; 18(6):880-6. PubMed ID: 24706314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IPF: New insight in diagnosis and prognosis.
    Caminati A; Harari S
    Respir Med; 2010 Jul; 104 Suppl 1():S2-10. PubMed ID: 20639137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of early suspected acute exacerbations of idiopathic pulmonary fibrosis with subsequent clinical outcomes and healthcare resource utilization.
    Yu YF; Macaulay DS; Reichmann WM; Wu EQ; Nathan SD
    Respir Med; 2015 Dec; 109(12):1582-8. PubMed ID: 26607877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic pulmonary fibrosis-epidemiology, causes, and clinical course].
    Schäfer SC; Funke-Chambour M; Berezowska S
    Pathologe; 2020 Feb; 41(1):46-51. PubMed ID: 31993696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
    Richeldi L
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Medicina (Kaunas); 2019 Mar; 55(3):. PubMed ID: 30884853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic pulmonary fibrosis: an Australian perspective.
    Prasad J; Holland AE; Glaspole I; Westall G
    Intern Med J; 2016 Jun; 46(6):663-8. PubMed ID: 27257148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia.
    Moua T; Zamora Martinez AC; Baqir M; Vassallo R; Limper AH; Ryu JH
    Respir Res; 2014 Dec; 15(1):154. PubMed ID: 25472884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
    Ryerson CJ; Cottin V; Brown KK; Collard HR
    Eur Respir J; 2015 Aug; 46(2):512-20. PubMed ID: 26232481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in idiopathic pulmonary fibrosis.
    Noth I; Martinez FJ
    Chest; 2007 Aug; 132(2):637-50. PubMed ID: 17699135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of Prognosis between Surgically and Clinically Diagnosed Idiopathic Pulmonary Fibrosis Using Gap Model: A Korean National Cohort Study.
    Lee SH; Kim SY; Kim DS; Kim YW; Chung MP; Uh ST; Park CS; Jeong SH; Park YB; Lee HL; Shin JW; Lee EJ; Lee JH; Jegal Y; Lee HK; Kim YH; Song JW; Park MS
    Medicine (Baltimore); 2016 Mar; 95(11):e3105. PubMed ID: 26986154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.